SightfileU.S. market data from official filings
Companies › CASIF
CASI PHARMACEUTICALS INC (CASIF)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001962738 · EDGAR filings · Updated 2026-07-15
CASI PHARMACEUTICALS INC (CASIF) has 1 institutional managers reporting positions valued at $25 per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.
Institutional managers
1
Reported 13F value
$25
Data flags
1 active
from SEC filings
Latest updates
- 2026-07-15 — Foreign issuer report (6-K) filed
- 2026-06-29 — Foreign issuer report (6-K) filed
- 2026-06-23 — 25-NSE filed
- 2026-06-02 — Foreign issuer report (6-K) filed
- 2026-05-18 — SCHEDULE 13D/A filed
- 2026-05-15 — Annual report (20-F) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, CASI PHARMACEUTICALS INC has 1 institutional holders.
Insider activity
Insiders reported 0 transactions (0 buys, 0 sells) across 3 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2025-03-31) — source filing. The authoritative details are those stated in the filing itself.
Related companies
HEALTHLYNKED CORP COM (HLYK) · PROTOKINETIX INC (PKTX) · ELITE PHARMACEUTICALS INC COM NEW (ELTP)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.